£245.57

Springer Infectious Complications of Cancer: 79 (Cancer Treatment and Research, 79)

Price data checked 7 days ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 1 month ago.

£246 today · all-time low £245 (Aug 2026) · usually £246

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 84 days · 84 data points (no recent data)

Historical
Generating forecast…
£248.28 £245.13 £245.82 £246.51 £247.19 £247.88 £248.57 07 June 2026 27 June 2026 18 July 2026 08 August 2026 29 August 2026

Price Distribution

Price distribution over 84 days • 2 price levels

Days at Price
Current Price
77 days · current 7 days 0 19 39 58 77 £246 £248 Days at Price

Price Analysis

Most common price: £246 (77 days, 91.7%)

Price range: £246 - £248

Price levels: 2 different prices over 84 days

Description

Despite the major developments in the therapeutic armamentarium for the treatment of infection, the morbidity and mortality of this complication remains very high in patients with compromised defences. Cancer and its treatment represents a major predisposing condition to a variety of infections. These adverse events are still with us, in spite of much progress in the therapy of infectious disease, since cancer therapy is becoming more aggressive, yet further lowering the host's capacity to cope with infections. Moreover, the pathogens adapt effectively to drugs, and at a pace that might outrun industry's capability to produce new agents. Finally, new pathogens are appearing as a consequence of both selection and severe immunosuppression. Infection is so common among cancer patients that its diagnosis and management represent a daily challenge to all oncologists, who must continually strive to keep abreast of developments in the area. The present comprehensive review of the most crucial and challenging aspects of the infectious complications in cancer patients will help them to do just that.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Inflammation, Infection, and Microbiome in Cancers: Evidence, Mechanisms, and Implications (Physiology in Health and Disease)
85% match

Inflammation, Infection, and Microbiome in Cancers: Evidence, Mechanisms, and Implications (Physiology in Health and Disease)

Springer

£108.91 08 Aug 2026
Complications of Cancer Therapy: Best Practices in Prevention and Management
84% match

Complications of Cancer Therapy: Best Practices in Prevention and Management

Springer

£52.80 08 Aug 2026
Infections in the Immunocompromised Host: Laboratory Diagnosis and Treatment: 202 (Advances in Experimental Medicine and Biology, 202)
83% match

Infections in the Immunocompromised Host: Laboratory Diagnosis and Treatment: 202 (Advances in Experimental Medicine and Biology, 202)

Springer

£76.42 04 Aug 2026
Innate and Adaptive Immunity in the Tumor Microenvironment: 1
83% match

Innate and Adaptive Immunity in the Tumor Microenvironment: 1

Springer

£76.42 13 Aug 2026
Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)
82% match

Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)

Springer

£113.76 12 Aug 2026
Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)
82% match

Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)

Springer

£166.02 07 Aug 2026
Basic and Clinical Tumor Immunology: 14 (Cancer Treatment and Research, 14)
82% match

Basic and Clinical Tumor Immunology: 14 (Cancer Treatment and Research, 14)

Springer

£164.55 07 Aug 2026
Bacteria and Cancer
82% match

Bacteria and Cancer

Springer

£108.01 07 Aug 2026
Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)
82% match

Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)

Springer

£149.05 05 Aug 2026
Cytokines and Cancer: 126 (Cancer Treatment and Research, 126)
82% match

Cytokines and Cancer: 126 (Cancer Treatment and Research, 126)

Springer

£113.76 06 Aug 2026
Infectious Complications in Biologic and Targeted Therapies
82% match

Infectious Complications in Biologic and Targeted Therapies

Springer

£80.64 02 Aug 2026
Current Cancer Therapeutics
82% match

Current Cancer Therapeutics

Springer

£72.12 30 Jul 2026
Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)
81% match

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

Springer

£113.76 05 Aug 2026
Nutritional Management of Cancer Treatment Effects
81% match

Nutritional Management of Cancer Treatment Effects

Springer

£80.65 08 Aug 2026
Cancer Immunotherapy: Immune Suppression and Tumor Growth
81% match

Cancer Immunotherapy: Immune Suppression and Tumor Growth

Academic Press

£88.00 13 Aug 2026
Therapy for Genitourinary Cancer: 59 (Cancer Treatment and Research, 59)
81% match

Therapy for Genitourinary Cancer: 59 (Cancer Treatment and Research, 59)

Springer

£129.10 07 Aug 2026
Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)
81% match

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Springer

£149.64 05 Aug 2026
Clinical Management of Malignant Melanoma: 21 (Cancer Treatment and Research, 21)
81% match

Clinical Management of Malignant Melanoma: 21 (Cancer Treatment and Research, 21)

Springer

£113.76 03 Jul 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
81% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£113.76 06 Aug 2026
Malignant Melanoma: Biology, Diagnosis, and Therapy: 43 (Cancer Treatment and Research)
81% match

Malignant Melanoma: Biology, Diagnosis, and Therapy: 43 (Cancer Treatment and Research)

Springer

£122.06 29 Aug 2026
Cancer Immunotherapy: Paradigms, Practice and Promise
81% match

Cancer Immunotherapy: Paradigms, Practice and Promise

Springer

£108.01 06 Aug 2026
Cancer Clinical Trials: Proactive Strategies: 132 (Cancer Treatment and Research, 132)
81% match

Cancer Clinical Trials: Proactive Strategies: 132 (Cancer Treatment and Research, 132)

Springer

£108.01 05 Aug 2026
Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)
80% match

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Springer

£165.38 06 Aug 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
80% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.67 05 Aug 2026